Negative effects of G-protein-coupled free fatty acid receptor GPR40 on cell migration and invasion in fibrosarcoma HT1080 cells

Molecular Carcinogenesis

Volumn 55, Issue 11, 2016, Pages 1553-1559

  Ishii, Shuhei ^a   Kitamura, Yuka ^a   Hirane, Miku ^a   Tomimatsu, Ayaka ^a   Fukushima, Kaori ^a   Takahashi, Kaede ^a   Fukushima, Nobuyuki ^a   Honoki, Kanya ^b   Tsujiuchi, Toshifumi ^a  

^a KINKI UNIVERSITY   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

cell motility; cisplatin; GPR40; invasion; sarcoma

Indexed keywords

CISPLATIN; G PROTEIN COUPLED RECEPTOR 40; GELATIN; GELATINASE A; GELATINASE B; GW 9508; RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG; CONDITIONED MEDIUM; FFAR1 PROTEIN, HUMAN; G PROTEIN COUPLED RECEPTOR; MMP2 PROTEIN, HUMAN; MMP9 PROTEIN, HUMAN; O3FAR1 PROTEIN, HUMAN;

ARTICLE; CELL FUNCTION; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; ENZYME ACTIVITY; FIBROSARCOMA; FIBROSARCOMA CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; LONG TERM CARE; PRIORITY JOURNAL; TREATMENT DURATION; TUMOR GROWTH; ZYMOGRAPHY; CELL MOTION; CHEMISTRY; CONDITIONED MEDIUM; DRUG EFFECTS; GENE EXPRESSION REGULATION; METABOLISM; TUMOR CELL LINE; TUMOR INVASION;

CELL LINE, TUMOR; CELL MOVEMENT; CISPLATIN; CULTURE MEDIA, CONDITIONED; FIBROSARCOMA; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84940783788     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.22408     Document Type: Article

References (25)

1. Venkatakrishnan AJ, Deupi X, Lebon G, Tate CG, Schertler GF, Babu MM. Molecular signatures of G-protein-coupled receptors. Nature 2013; 494:185–194.
2. Harber EP, Ximenes HMA, Procópio J, Carvalho CRO, Curi R, Carpinelli AR. Pleiotropic effects of fatty acids on pancreatic beta-cells. J Physiol 2003; 194:1–12.
3. Brown AJ, Jupe S, Briscoe CP. A family of fatty acid binding receptors. DNA Cell BIol 2005; 24:54–61.
4. Hara T, Kashihara D, Ichimura A, Kimura I, Tsujimoto G, Hirasaewa A. Role of free fatty acid receptors in the regulation of energy metabolsm. Biochim Biophys Acta. 2014; 1841:1292–1300.
5. Briscoe CP, Tadayyon M, Andrews JL, et al. The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids. J Biol Chem. 2003; 278:11303–11311.
6. Itoh Y, Kawamata Y, Harada M, et al. Free fatty acids regulate insulin secretion from pancreatic beta cells through GPRPR40. Nature 2003; 422:173–176.
7. Hara T, Hirasawa A, Ichimura A, Kimura I, Tsujimoto G. Free fatty acid receptors FFAR1 and GPR120 as novel therapeutic targets for metabolic disorders. J Pharm Sci. 2011; 100:3594–3601.
8. Wu Q, Wang H, Zhao X, et al. Identification of G-protein-coupled receptor 120 as a tumor-promoting receptor that induces angiogenesis and migration in human colorectal carcinoma. Oncogene 2013; 32:5541–5550.
9. Ishii S, Hirane M, Kitamura Y, et al. Role of GPR120 in cell motile activity induced by 12-O-tetradecanoylphorbol-13-acetate in liver epithelial WB-F344 cells. Mol Cell Biochem. 2015; 400:145–151.
10. Ishii S, Hirane M, Kato S, Fukushima N, Tsujiuchi T. Opposite effects of GPR120 and GPR40 on cell motile activity induced by ethionine in liver epithelial cells. Biochem Biophys Res Commun. 2015; 456:135–138.
11. Folpe AL. Fibrosarcoma: A review and update. Histopathology 2014; 64:12–25.
12. Shano S, Hatanaka K, Ninose S, et al. A Lysophosphatidic acid receptor lacking the PDZ-binding domain is constitutively active and stimulates cell proliferation. Biochim Biophys Acta. 2008; 1783:748–759.
13. Tanabe E, Kitayoshi M, Yoshikawa K, et al. Loss of lysophosphatidic acid receptor-3 suppresses cell migration activity of humna sarcoma cells. J Recept Sig Transd. 2012; 32:328–334.
14. 6 on the activation of tumor progression in pancreatic cancer cells. Biochem Biophys Res Commun. 2015; 461:59–64.
15. Tomita T, Masuzaki H, Iwakura H, et al. Expression of the gene for a membrane-bound fatty acid receptor in the pancreas and islet cell tumours in humans: Evidence for GPR40 expression in pancreatic beta cells and implications for insulin secretion. Diabetologia 2006; 49:962–968.
16. Odori S, Hosoda K, Tomita T, et al. GPR119 expression in normal human tissues and islet cell tumors: Evidence for its islet-gastrointestinal distribution, expression in pancreatic beta and alpha cells, and involvement in islet function. Metabolims 2013; 62:70–78.
17. Hirasawa A, Tsumaya K, Awaji T, et al. Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nature Med 2005; 11:90–94.
18. Gotoh C, Hong YH, Iga T, et al. The regulation of adipogenesis through GPR120. Biochem Biophys Res Commun 2007; 354:591–597.
19. Oh DY, Talukdar S, Bae EJ, et al. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 2010; 142:687–698.
20. Briscoe CP, Peat AJ, McKeown SC, Corbett DF, et al. Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GP R40: Identification of agonist and antagonist small molecules. Br J Pharmacol 2006; 148:619–628.
21. Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: Regulators of the tumor microenvironment. Cell 2010; 141:52–67.
22. Bauvous B. New facets of matrix metalloproteinase MMP-2 and MMP-9 as cell surface transducers: Outside-in signaling and relationship to tumor progression. Biochim Biophys Acta. 2012; 1825:29–36.
23. Mokady D, Meiri D. RhoGTPases - a novel link between cytoskeleton organization and cisplatin resistance. Drug Resist Updat. 2015; 19:22–32.
24. Croft DR, Olson MF. Transcriptional regulation of Rho GTPase signaling. Transcription 2011; 2:211–215.
25. Wells A, Grahovac J, Wheeler S, Ma B, et al. Targeting tumor cell motility as a strategy against invasion and metastasis. Trends Pharmacol Sci. 2013; 34:283–289.